|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 322.90 USD | -2.56% |
|
-5.20% | +74.81% |
| 11-26 | Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Ahead of Key Economic Data Deluge | MT |
| 11-26 | BeOne Medicine Wins FDA Priority Review for Mantle Cell Lymphoma Drug | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| -.--% | -.--% | 103.74x | 8.94x | 6.32x | 63.39x | 98.05x | 35.73B | ||
| 0.92% | 1.04% | 37.75x | 3.89x | 5.5x | 18.58x | 27.1x | 47.37B | ||
| -.--% | -.--% | 31.8x | 6.06x | 3.2x | 13.81x | 21.65x | 38.46B | ||
| 0.4% | 0.43% | 51.48x | 2.28x | 9.93x | 28.1x | 36.53x | 27.23B | ||
| -.--% | -.--% | 37.03x | 36.97x | 5.99x | 27.2x | 28.5x | 15.44B | ||
| -.--% | -.--% | -14.27x | 9.7x | 5565.23x | -13.44x | -13.27x | 15.4B | ||
| -.--% | -.--% | 28.78x | 1.52x | 2.13x | 10.9x | 12.12x | 14.19B | ||
| -.--% | -.--% | -51.58x | 33.61x | 11.12x | 28622.4x | -206.5x | 13.64B | ||
| -.--% | -.--% | -36.27x | 48.05x | 13.75x | -39.24x | -34.39x | 13.23B | ||
| -.--% | -.--% | -52.16x | 1358.43x | 14.89x | -122.01x | -86.46x | 12.55B | ||
| 1.08% | 1.18% | 23.08x | 2.02x | 1.93x | 8.76x | 13.42x | 12.12B | ||
| 0.44% | 0.4% | 24.46x | 2.72x | 5.06x | 13.7x | 17.09x | 10.19B | ||
| 0.52% | 0.52% | 48.06x | 4.42x | 7.8x | 22.01x | 24x | 9.61B | ||
| -.--% | -.--% | 43.95x | 2.58x | 2.75x | 11.41x | 13.89x | 9.07B | ||
| 0.71% | 0.87% | 29.65x | 3.43x | 3.64x | 15x | 23.58x | 6.92B | ||
| -.--% | -.--% | -18.97x | 6.52x | 21426.23x | -18.44x | -17.85x | 6.2B | ||
| Average | 0.25% | 0.28% | 17.91x | 95.69x | 1,692.84x | 1,791.38x | -2.66x | 17.96B | |
| Weighted average by Cap. | 0.28% | 0.31% | 29.65x | 69.14x | 766.55x | 1,369.93x | 11.87x |
- Stock Market
- Equities
- ONC Stock
- Sector BeOne Medicines AG
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















